Medical Properties Trust Inc expected to post earnings of 7 cents a share - Earnings Preview

Medical Properties Trust

07/05/2024 19:16

* Medical Properties Trust Inc  MPW.N   MPW  is expected
to show a
fall in quarterly revenue when it reports  results on May 9 for
the period ending March 31 2024
    * The Birmingham Alabama-based  company is expected to
report a
21.1% decrease in revenue to $276.455 million from $350.21
million a year ago, according to the mean estimate from 7
analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for Medical Properties Trust
Inc
is for earnings of 7 cents per share. 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 7
"hold" and 4 "sell" or "strong sell."  
    * The mean earnings estimate of analysts had fallen by
about 3.3%
in the last three months. ​
    * Wall Street's median 12-month price target for Medical
Properties Trust Inc is $5.00​, above​ its last closing price
of $4.50. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Dec. 31 2023  0.28        0.30       0.36      Beat    21.4
 Sep. 30 2023  0.35        0.36       0.38      Beat    7
 Jun. 30 2023  0.37        0.37       0.48      Beat    28.8​
 Mar. 31 2023  0.38        0.37       0.37      Met     -1.2
 ​​Dec.        0.43        0.43       0.43      Met     -0.3
 31 2022                                                
 Sep. 30 2022  0.45        0.45       0.45      Met     0.1​
 Jun. 30 2022  0.45        0.45       0.46      Beat    2.6
 Mar. 31 2022  0.47        0.47       0.47      Met     -0.2
 This summary was machine generated May 7 at 18:15 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)